
GlaxoSmithKline features prominently in the news this week, as they pledged to pay a cash bonus of £1,500 to staff …

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of …

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …

This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …

Happy Friday! It’s time for another rundown of the top 10 most popular articles with Pharmafile.com readers this week.10. NICE …

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …

HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

News that the FDA’s advisory panel had recommended Janssen’s intranasal esketamine spray Spravato as a treatment for treatment resistant depression, …

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …